TransMedics (TMDX) Shareholder's Equity (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.42% |
| Dec 31, 2025 | 33.19% |
| Sep 30, 2025 | 11.66% |
| Jun 30, 2025 | 19.45% |
| Mar 31, 2025 | 16.49% |
| Dec 31, 2024 | 8.90% |
| Sep 30, 2024 | 10.55% |
| Jun 30, 2024 | 19.08% |
| Mar 31, 2024 | 16.23% |
| Dec 31, 2023 | 8.49% |
| Sep 30, 2023 | -12.91% |
| Jun 30, 2023 | -24.61% |
| Mar 31, 2023 | 2.80% |
| Dec 31, 2022 | -0.26% |
| Sep 30, 2022 | 268.93% |
| Jun 30, 2022 | -15.01% |
| Mar 31, 2022 | -11.71% |
| Dec 31, 2021 | -13.62% |
| Sep 30, 2021 | -11.73% |
| Jun 30, 2021 | -8.90% |
| Mar 31, 2021 | -5.98% |
| Dec 31, 2020 | -5.17% |
| Sep 30, 2020 | -3.70% |
| Jun 30, 2020 | 143.69% |
| Mar 31, 2020 | -14.58% |
| Dec 28, 2019 | -13.90% |
| Sep 28, 2019 | -10.81% |
| Jun 29, 2019 | 135.75% |
| Mar 30, 2019 | -3.54% |
| Dec 29, 2018 | -4.09% |
| Sep 29, 2018 | -2.80% |
| Jun 30, 2018 | -3.50% |